Nat Prod Sci.  2017 Jun;23(2):119-124. 10.20307/nps.2017.23.2.119.

Neolignan Derivatives from the Flower of Magnolia biondii Pamp. and their Effects on IL-2 expression in T-cells

Affiliations
  • 1College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea. jkim6923@knu.ac.kr
  • 2School of Life Sciences, Immune Synapse Research Center and Cell Dynamics Research Center, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
  • 3College of Pharmacy, Drug Research and Development Center, Catholic University of Daegu, Gyeongbuk 38430, Republic of Korea.

Abstract

The isolation of the MeOH extract from the flower bud of Magnolia biondii Pamp. using various column chromatographies and HPLC led to eleven neoglignan derivatives (1 - 11). Their structures were mainly determined by 1D and 2D NMR spectral data analysis and physiological methods. The isolated compounds (1 - 11) were tested for anti-allergic effects using IL-2 inhibitory assay in Jurkat T cells.

Keyword

Magnolia biondii Pamp.; Magnoliaceae; Neolingnan; Anti-allergy; IL-2

MeSH Terms

Chromatography
Chromatography, High Pressure Liquid
Flowers*
Interleukin-2*
Magnolia*
Magnoliaceae
Statistics as Topic
T-Lymphocytes*
Interleukin-2

Figure

  • Fig. 1. Chemical structures of neolignans 1 – 11 isolated from the flower of Magnolia biondii Pamp.

  • Fig. 2. Inhibition of IL-2 expression and cell viability by neolignans 1–11 isolated from M. biondii. A) Jurkat T cells (1 × 106) were treated with 50 µM concentrations of 1 – 11 for 30 min and stimulated with PMA (100 nM)/A23187 (1 µM) for 6 h. After incubation, cells were harvested and total RNA was isolated from harvested cells. Human IL-2 mRNA levels were detected by conventional PCR. B) Jurkat T cells (3×105) were seeded in a 24 well-plate and incubated with 50 µM concentrations of 1–11 for 24 h. After incubation, cell viability was examined by MTT assay. Data was shown as percentages compared to cell viability treated with Mock control.


Reference

References

(1). Park C. S.., Kim T. B.., Lee J. Y.., Park J. Y.., Lee Y. C.., Jeong S. S.., Lee Y. D.., Cho Y. S.., Moon H. B.Korean J. Intern. Med. 2012. 27:84–90.
(2). Song Q.., Fischer N. H.Rev. Soc. Quím. Mex. 1999. 43:211–218.
(3). Marin G. H.., Mansilla E.., Ciocchini S.., Quiroga N.., Cardozo N.., Weiss M.., Gustavo H. M.., Trebucq H.Annalen der Chemischen Forschung. 2013. 1:50–55.
(4). Lee S.., Chappell J.Plant Physiol. 2008. 147:1017–1033.
(5). Haraguchi H.., Ishikawa H.., Shirataki N.., Fukuda A. J.Pharm. Pharmacol. 1997. 49:209–212.
(6). Syu W. J.., Shen C. C.., Lu J. J.., Lee G. H.., Sun C. M.Chem. Biodivers. 2004. 1:530–537.
(7). Kuo W. L.., Chung C. Y.., Hwang T. L.., Chen J. J.Phytochemistry. 2013. 85:153–160.
(8). Akber U.., Na B. R.., Ko Y. S.., Lee H. S.., Kim H. R.., Kwon M. S.., Park Z. Y.., Choi E. J.., Han W. C.., Lee S. H.., Oh H. M.., Jun C. D.Int. Immunopharmacol. 2015. 25:130–140.
(9). Hershko A. Y.., Suzuki R.., Charles N.., Alvarez-Errico D.., Sargent J. L.., Laurence A.., Rivera J.Immunity. 2011. 35:562–571.
(10). Chen C. C.., Huang Y. L.., Chen Y. P.., Hsu H. Y.., Kuo Y. H.Chem. Pharm. Bull. 1988. 36:1791–1795.
(11). Tyagi O. D.., Jensen S.., Boll P. M.., Sharma N. K.., Bisht K. S.., Parmar V. S.Phytochemistry. 1993. 32:445–448.
(12). Ponpipom M. M.., Bugianesi R. L.., Brooker D. R.., Yue B. Z.., Hwang S. B.., Shen T. Y. J.Med. Chem. 1987. 30:136–142.
(13). Wenkert E.., Gottlieb H. E.., Gottlieb O. R.., Pereira M. O. S.., Formiga M. D.Phytochemistry. 1976. 15:1547–1551.
(14). Jensen S.., Olsen C. E.., Tyagi O. D.., Boll P. M.., Hussaini F. A.., Gupta S.., Bisht K. S.., Parmar V. S.Phytochemistry. 1994. 36:789–792.
(15). Tyagi O. D.., Wengel J.., Prasad A. K.., Boll P. M.., Olsen C. E.., Pati H. N.., Bisht K. S.., Parmar V. S.Acta Chem. Scand. 1994. 48:1007–1011.
(16). El-Feraly F. S.., Cheatham S. F.., Hufford C. D.., Li W. S.Phytochemistry. 1982. 21:1133–1135.
(17). Pieters L.., de Bruyne T.., Claeys M.., Vlietinck A.., Calomme M.., vanden Berghe D. J.Nat. Prod. 1993. 56:899–906.
(18). Kuroyanagi M.., Yoshida K.., Yamamoto A.., Miwa M.Chem. Pharm. Bull. 2000. 48:832–837.
(19). Du J.., Wang M. L.., Chen R. Y.., Yu D. Q. J.Asian Nat. Prod. Res. 2001. 3:313–319.
(20). Kasperska-Zajac A.., Brzoza Z.., Rogala B.Recent Pat. Inflamm. Allergy Drug Discov. 2008. 2:72–76.
(21). Noshita T.., Funayama S.., Hirakawa T.., Kidachi Y.., Ryoyama K.Biosci. Biotechnol. Biochem. 2008. 72:2775–2778.
(22). Reddy S. D.., Siva B.., Poornima B.., Kumar D. A.., Tiwari A. K.., Ramesh U.., Babu K. S.Pharmacogn. Mag. 2015. 11:235–241.
Full Text Links
  • NPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr